The content on this site is intended for healthcare professionals only
Dr Plesner talks to ecancertv at ICMM 2016 about the use of CD38 monoclonal antibodies for patients with multiple myeloma.
For more on this topic, see our interview with Dr Van De Donk and Prof Mateos. Interivew with Prof Moreau coming soon.
ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.
Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients
Advancements in minimal residual disease detection in myeloma
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Treating relapsed multiple myeloma outside of use of T-cell redirected therapies
Guiding transplant decisions in multiple myeloma with MRD
Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
Choosing 1st line TKI Wisely in patients with CML
ESMO 2024: Latest in EGFR mutated NSCLC
